Sodium 1,2-Dipalmitoyl-sn-glycero-3-phospho-(1'-rac-glycerol) Withdrawn Phase N/A Trials for Hepatocellular,Carcinoma Diagnostic

IndicationsStatusPurposePhase
WithdrawnDiagnosticNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT03300401Contrast-Enhanced Ultrasound in Diagnosing Patients With Liver Cancer Undergoing Yttrium-90 Radioembolization